financial results NanoString Technologies Touts Interest in CosMx Spatial Biology Platform at JPM The Seattle-based company has already sold 20 platforms ahead of the Q4 launch, and researchers are receiving data from the CosMx Technology Access Program. Bionano Genomics Expecting Sharp Increases in Q4, Full-Year 2021 Revenues The San Diego-based company said the installed base of its Saphyr optical genome mapping system reached 164 at the end of the year, topping expectations. PacBio Prelim Q4 Revenues up 33 Percent; Firm Partners With Google, Berry Genomics, Genomics England PacBio reported preliminary Q4 revenues of $36 million and full-year revenues of about $130.5 million, both falling short of analyst estimates. Akoya, Olink, NanoString, Adaptive Bio, Sema4, Oxford Nanopore Report Preliminary Financial Results The life science tools companies provided anticipated revenue results for the fourth quarter and full-year 2021. CareDx, Castle Bio, Lucira Health, Others Announce Preliminary Q4, FY21 Earnings Results CareDx's Q4 revenues rose between 34 percent and 35 percent, while OpGen Q4 revenues were flat compared to the previous year. Jan 10, 2022 Hologic Preliminary Fiscal Q1 Revenues Drop 9 Percent Jan 6, 2022 HTG Molecular Expects 5 Percent Rise in 2021 Revenues Jan 5, 2022 Berkeley Lights Preliminary 2021 Revenues Fall Short of Expectations; Firm Searching for New CEO Dec 15, 2021 Enzo Biochem Q1 2022 Revenues Down 8 Percent Dec 9, 2021 Applied DNA Sciences Fiscal Q4 Revenues Skyrocket Nov 30, 2021 Genetron Health Q3 Revenues up 36 Percent, Firm Announces AstraZeneca MRD Partnership Nov 24, 2021 Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business Nov 23, 2021 Seegene Posts 7 Percent Decline in Q3 Revenues Due to Reduction in COVID Testing Nov 22, 2021 Agilent Q4 Revenues Rise 12 Percent Nov 17, 2021 Newly Public Lucid Diagnostics Posts $200K in Preliminary Q3 Revenues Nov 16, 2021 Burning Rock Q3 Revenues Inch up 2 Percent Nov 15, 2021 Sema4 Q3 Revenues Rise 12 Percent Nov 15, 2021 Biocept Q3 Revenues Jump 165 Percent on COVID-19 Testing Impact Nov 15, 2021 Talis Biomedical Q3 Revenues Plummet on Lower Grant Revenues Nov 15, 2021 SomaLogic Q3 Revenues Grow 40 Percent Nov 15, 2021 Biodesix Q3 Revenues Down 29 Percent on Lower COVID-19 Test Sales but Tops Estimates Nov 12, 2021 Meridian Bioscience Q4 Revenues Climb 19 Percent Nov 12, 2021 OpGen Q3 Revenues Climb 9 Percent Nov 11, 2021 Lucira Health Posts $15M in Q3 Revenues Nov 11, 2021 Interpace Biosciences Q3 Revenues Rise 15 Percent Load More Breaking News Pediatric Cardiomyopathy Exome Sequencing Study Suggests More Disease Genes to be Found People in the News: New Appointments at Helix, Pacific Biosciences, SomaLogic, More New Products Posted to GenomeWeb: Amoy Diagnostics, Akoya Biosciences, Congenica, Lucence In Brief This Week: BGI, Gencove, Cepheid, Biocartis, Biognosys, Co-Diagnostics, More Florida Lab Owner Pleads Guilty to $6.9M COVID-19 False Billing Scheme Pacific Biosciences Outlines Progress on Short-Read Sequencing at JPM, Partners With Canexia Health The Scan Close Panel Vote on Califf Nomination The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate. Task Force Reports on Scientific Integrity Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council. Across the Hall Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports. Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder In Science this week: genes regulating chromatin modification may contribute to OCD risk.